Avinger raises $5.3 million via at-the-market facility

Strengthens balance sheet in support of tigereye st launch and coronary product development redwood city, ca / accesswire / september 27, 2023 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that is has raised gross proceeds of approximately $5.3 million through its at-the-market (atm) facility in september 2023, selling an aggregate of 596,200 shares of common stock at a weighted average price of $8.97. net proceeds from the transactions were approximately $5.2 million after deducting sales commissions.
AVGR Ratings Summary
AVGR Quant Ranking